The International Cancer of the Pancreas Screening Consortium indicates the screening for PDAC onset in patients with Peutz–Jeghers syndrome, with presence of STK11 mutation; with presence of a CDKN2A, BRCA1/2, or MMR mutation and with a first-degree relative affected with PDAC [52]. Here, CDKN2A is linked to cancer.